Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome

Infection. 2023 Apr;51(2):519-522. doi: 10.1007/s15010-022-01949-x. Epub 2022 Nov 10.

Abstract

In July 23, the World Health Organization (WHO) declared monkeypox (MPX) a global health emergency of international concern given its rapid spread. So far, most current MPX outbreaks have involved young men who have sex with men (MSM), although with overall mild, self-limiting clinical manifestations. We aim to describe the case of an HIV positive young MSM whose status of immune compromission probably contributed to a more severe clinical course of MPX disease, thus requiring hospitalization and antiviral treatment. He was effectively treated with Cidofovir that may be considered as a valuable component of a multi-faceted management of severe MPX.

Keywords: AIDS; Cidofovir; Monkeypox.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome*
  • Cidofovir / therapeutic use
  • Homosexuality, Male
  • Humans
  • Male
  • Mpox (monkeypox)* / diagnosis
  • Mpox (monkeypox)* / drug therapy
  • Sexual and Gender Minorities*

Substances

  • Cidofovir